Literature DB >> 20716161

Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.

Lin Yu1, Wentao Yang, Xu Cai, Daren Shi, Yuezhen Fan, Hongfen Lu.   

Abstract

AIMS: To investigate the clinicopathological features and immunophenotype of centrally necrotizing carcinoma (CNC) of the breast to ascertain its relationship to basal-like phenotype and its prognosis. METHODS AND
RESULTS: The clinical and pathological characteristics of 33 CNCs were reviewed. Immunohistochemical study of oestrogen receptor, progesterone receptor, HER2, cytokeratin (CK) 8/18, high-molecular-weight CK (34betaE12), CK5/6, CK14, CK17, smooth muscle antigen, p63, vimentin and epidermal growth factor receptor was performed. The striking feature of CNC was a central, necrotic or acellular zone surrounded by a ring-like area of viable tumour cells. The central zone showed three morphological types: predominance of coagulative necrosis (21 cases), predominance of fibrosis and scar tissue (nine cases) and infarction (three cases). Tumour cells displayed invasive ductal carcinoma of high grade. The expression rate of basal-like markers was higher than that of myoepithelial markers (87.9% versus 46.2%). Basal-like subtype was shown by 63.6% of cases. The expression rate of CK5/6 (90.5%) was highest among basal-like markers. Follow-up data of 19 patients were available. Median progression-free survival was 15.5 months. In 12 patients (63.2%), local recurrence and/or distant metastasis developed (median time to recurrence and/or metastasis, 14.0 months).
CONCLUSIONS: CNC has distinctive morphological features, which mostly exhibit a basal-like immunophenotype and poor prognosis. CNC is a typical representative of basal-like breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716161     DOI: 10.1111/j.1365-2559.2010.03601.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells.

Authors:  Wei Bin Fang; Min Yao; Iman Jokar; Nabil Alhakamy; Cory Berkland; Jin Chen; Dana Brantley-Sieders; Nikki Cheng
Journal:  Breast Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.872

2.  Shear wave elastography of tumour growth in a human breast cancer model with pathological correlation.

Authors:  Foucauld Chamming's; H Latorre-Ossa; M A Le Frère-Belda; V Fitoussi; T Quibel; F Assayag; E Marangoni; G Autret; D Balvay; L Pidial; J L Gennisson; M Tanter; C A Cuenod; O Clément; L S Fournier
Journal:  Eur Radiol       Date:  2013-04-04       Impact factor: 5.315

3.  BRCA1-IRIS overexpression promotes formation of aggressive breast cancers.

Authors:  Yoshiko Shimizu; Hugh Luk; David Horio; Penelope Miron; Michael Griswold; Dirk Iglehart; Brenda Hernandez; Jeffrey Killeen; Wael M ElShamy
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

4.  Clinicopathological study of centrally necrotizing carcinoma of the breast.

Authors:  Yanling Zhang; Yurong Ou; Donghong Yu; Xiang Yong; Xiaoli Wang; Bo Zhu; Qiong Zhang; Lei Zhou; Zhaogen Cai; Zenong Cheng
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

5.  Diagnostic pitfall in a case of ductal carcinoma-in situ with microinvasion.

Authors:  Yasmin A Momin; Medha P Kulkarni; Bhakti D Deshmukh; Kalpana R Sulhyan
Journal:  J Cytol       Date:  2016 Apr-Jun       Impact factor: 1.000

6.  Centrally necrotizing breast carcinoma: a rare histological subtype, which was cause of misdiagnosis in an evident clinical local recurrence.

Authors:  Fernando Hernanz; Pilar Alonso-Bartolomé; Irene González-Rodilla
Journal:  World J Surg Oncol       Date:  2012-08-01       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.